Infographic: Long-term sexual health outcomes in men with classic bladder exstrophy
Infographic: Long-term sexual health outcomes in men with classic bladder exstrophy
Author Archive for: admin Z.9
Entries by admin Z.9
September 2017 – About the Cover
This issue’s Article of the Month comes from The James Buchanan Brady Urological Institute, Baltimore, MD, established over 100 years ago by “Diamond Jim” Brady. The cover image shows the Johns Hopkins University School of Medicine. ©istock.com/UmerPK Click here for this issue’s Table of Contents
What’s the Diagnosis?
This image is taken from Drake et al, BJUI 2017
Article of the Month: Long-term sexual health outcomes in men with classic bladder exstrophy
Every Month the Editor-in-Chief selects an Article of the Month from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the article […]
Editorial: Sexuality in men with exstrophy
It is always exciting to get new data on exstrophy from Johns Hopkins, but especially when sexual development is the subject [1]. It is the only unit with enough patients on continuous follow-up to overcome the difficulties of researching such a rare condition. In the last 40 years, patients born with exstrophy have achieved a near normal […]
Article of the Week: Sentinel node biopsy for prostate cancer: report from a consensus panel meeting
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the article itself, […]
What’s the Diagnosis?
From Grahn et al, BJUI 2017
Editorial: Sentinel nodes in prostate cancer– are we chasing a ghost?
Van der Poel et al. [1] report the findings of a consensus panel meeting on sentinel node (SN) biopsy at the time of radical prostatectomy. The consensus process was based on a two-round Delphi survey on the current evidence and knowledge gaps on SN detection. Then, a number of experts among those who answered the survey were invited […]
What’s the Diagnosis?
From Grahn et al, BJUI 2017
NICE Guidance: Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
Overview Evidence-based recommendations on enzalutamide (Xtandi) for treating metastatic, hormone-relapsed prostate cancer for people in whom chemotherapy is not yet clinically indicated. Summary of Appraisal Committee’s Key Conclusions TA377 Appraisal title: Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is clinically indicated Section Key conclusion Enzalutamide is recommended, within its marketing authorisation, as an […]